Aardvark Therapeutics, Inc. Common Stock (AARD) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Aardvark Therapeutics, Inc. Common Stock (AARD) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

AARD Income Statement

Aardvark Therapeutics, Inc. Common Stock (AARD) annual income statement — 4-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	15.08M	22.46M	18.7M	17.7M	15.85M	10.47M	9.45M	5.09M	6.07M	2.17M	2.23M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	4.63M	5.9M	4.41M	3.97M	2.7M	2.71M	1.39M	1.03M	2.03M	861K	525K
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Research & Development	10.46M	16.57M	14.3M	13.74M	13.14M	7.75M	8.06M	4.07M	4.03M	1.21M	1.54M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	14K	103K	171K
Operating Income	-15.08M	-22.46M	-18.7M	-17.7M	-15.85M	-10.47M	-9.45M	-5.09M	-6.07M	-2.17M	-2.23M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	4.82%	-114.56%	-97.93%	-247.73%	-160.96%	-382.27%	-323.2%	-	-	-	-
EBITDA	-14.39M	-22.45M	-18.69M	-17.69M	-15.84M	-10.46M	-8.78M	-5.08M	-6.03M	-2.17M	-2.21M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	9.16%	-114.55%	-112.94%	-248.08%	-162.85%	-382.48%	-297.6%	-	-	-	-
D&A (Non-Cash Add-back)	0	11K	10K	10K	11K	5K	0	8K	48K	2K	25K
EBIT	-14.39M	-21.59M	-17.6M	-16.32M	-14.37M	-9.31M	-8.78M	-4.18M	-6.06M	-2.18M	-2.06M
Net Interest Income	695K	889K	1.13M	1.35M	1.49M	1.18M	717K	1M	594K	103K	118K
Interest Income	695K	889K	1.13M	1.35M	1.49M	1.18M	717K	1M	594K	103K	118K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	697K	876K	1.11M	1.39M	1.48M	1.16M	671K	909K	624K	-7K	192K
Pretax Income	-14.39M	-21.59M	-17.6M	-16.32M	-14.37M	-9.31M	-8.78M	-4.18M	-5.45M	-2.18M	-2.04M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-14.39M	-21.59M	-17.6M	-16.32M	-14.37M	-9.31M	-8.78M	-4.18M	-5.45M	-2.18M	-2.04M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.14%	-131.88%	-100.46%	-290.15%	-163.66%	-327.46%	-330.13%	-	-	-	-
Net Income (Continuing)	-14.39M	-21.59M	-17.6M	-16.32M	-14.37M	-9.31M	-8.78M	-4.18M	-5.45M	-2.18M	-2.04M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.66	-0.99	-0.81	-0.75	-0.66	-0.43	-0.40	-0.20	-0.25	-0.10	-0.10
EPS Growth %	0%	-130.23%	-102.5%	-275%	-164%	-330%	-319.29%	-	-	-	-
EPS (Basic)	-0.66	-0.99	-0.81	-0.75	-0.66	-0.43	-0.40	-0.20	-0.25	-0.10	-0.10
Diluted Shares Outstanding	21.85M	21.82M	21.82M	21.75M	21.69M	21.69M	21.7M	21.38M	21.38M	21.38M	21.38M
Basic Shares Outstanding	21.85M	21.82M	21.82M	21.75M	21.69M	21.69M	21.7M	21.38M	21.38M	21.38M	21.38M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-